Bartholomew R. Bono

940 total citations
5 papers, 361 citations indexed

About

Bartholomew R. Bono is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Bartholomew R. Bono has authored 5 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 3 papers in Infectious Diseases and 2 papers in Surgery. Recurrent topics in Bartholomew R. Bono's work include Antibiotic Resistance in Bacteria (2 papers), Pneumonia and Respiratory Infections (2 papers) and Genetic factors in colorectal cancer (1 paper). Bartholomew R. Bono is often cited by papers focused on Antibiotic Resistance in Bacteria (2 papers), Pneumonia and Respiratory Infections (2 papers) and Genetic factors in colorectal cancer (1 paper). Bartholomew R. Bono collaborates with scholars based in United States. Bartholomew R. Bono's co-authors include Jerry M. Zuckerman, Patrick J. Loehrer, Richard H. Knop, Robert Dreicer, Robert S. Witte, Paul Elson, Camille E. Introcaso, Misha Rosenbach, Melissa Bleicher and Marc S. Levine and has published in prestigious journals such as Journal of Clinical Oncology, Transplantation and Infectious Disease Clinics of North America.

In The Last Decade

Bartholomew R. Bono

5 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bartholomew R. Bono United States 4 168 106 58 57 50 5 361
Sukij Panpimanmas Thailand 11 207 1.2× 32 0.3× 54 0.9× 48 0.8× 122 2.4× 35 349
Taweesak Tongtawee Thailand 13 248 1.5× 47 0.4× 71 1.2× 65 1.1× 114 2.3× 47 438
Ryan A Loyd Thailand 12 208 1.2× 28 0.3× 68 1.2× 30 0.5× 89 1.8× 37 352
Santiago Martínez Argentina 9 66 0.4× 190 1.8× 40 0.7× 13 0.2× 79 1.6× 16 340
Carol A. Olson United States 9 116 0.7× 129 1.2× 35 0.6× 18 0.3× 29 0.6× 9 321
A Rossolini Italy 8 338 2.0× 58 0.5× 10 0.2× 31 0.5× 79 1.6× 31 512
Konstanze Vogt Germany 11 227 1.4× 52 0.5× 7 0.1× 21 0.4× 37 0.7× 22 408
P Cahen France 10 19 0.1× 63 0.6× 43 0.7× 49 0.9× 27 0.5× 26 327
Yasuo Hayashida Japan 11 86 0.5× 62 0.6× 16 0.3× 72 1.3× 52 1.0× 50 354
Abiye Tigabu Ethiopia 11 28 0.2× 112 1.1× 31 0.5× 95 1.7× 30 0.6× 23 387

Countries citing papers authored by Bartholomew R. Bono

Since Specialization
Citations

This map shows the geographic impact of Bartholomew R. Bono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bartholomew R. Bono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bartholomew R. Bono more than expected).

Fields of papers citing papers by Bartholomew R. Bono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bartholomew R. Bono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bartholomew R. Bono. The network helps show where Bartholomew R. Bono may publish in the future.

Co-authorship network of co-authors of Bartholomew R. Bono

This figure shows the co-authorship network connecting the top 25 collaborators of Bartholomew R. Bono. A scholar is included among the top collaborators of Bartholomew R. Bono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bartholomew R. Bono. Bartholomew R. Bono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Bono, Bartholomew R., et al.. (2013). Patients With Recalcitrant Clostridium difficile–Associated Diarrhea Treated Successfully With Fidaxomicin. Infectious Diseases in Clinical Practice. 22(2). 92–95. 2 indexed citations
2.
Hamilton, Keith, Peter L. Abt, Misha Rosenbach, et al.. (2011). Donor-Derived Strongyloides stercoralis Infections in Renal Transplant Recipients. Transplantation. 91(9). 1019–1024. 65 indexed citations
3.
Zuckerman, Jerry M., et al.. (2011). Review of Macrolides (Azithromycin, Clarithromycin), Ketolids (Telithromycin) and Glycylcyclines (Tigecycline). Medical Clinics of North America. 95(4). 761–791. 78 indexed citations
4.
Zuckerman, Jerry M., et al.. (2009). Macrolides, Ketolides, and Glycylcyclines: Azithromycin, Clarithromycin, Telithromycin, Tigecycline. Infectious Disease Clinics of North America. 23(4). 997–1026. 61 indexed citations
5.
Witte, Robert S., Paul Elson, Bartholomew R. Bono, et al.. (1997). Eastern Cooperative Oncology Group phase II trial of ifosfamide in the treatment of previously treated advanced urothelial carcinoma.. Journal of Clinical Oncology. 15(2). 589–593. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026